Literature DB >> 8537117

Isolation and characterization of cDNA clones for Humly9: the human homologue of mouse Ly9.

M S Sandrin1, M M Henning, M F Lo, E Baker, G R Sutherland, I F McKenzie.   

Abstract

Ly9 is a mouse cell membrane antigen found on all lymphocytes and coded for by a gene that maps to chromosome 1. We previously described the isolation and characterization of a full-length cDNA clone for mouse Ly9. Using cross-species hybridization we isolated cDNA clones encoding the human homologue Humly9. Analysis of the predicted protein sequence suggests that the extra-cellular portion of the Humly9 molecules is composed of four Ig-like domains: a V domain (V) without disulphide bonds and a truncated C2 domain (tC2) with two disulphide bonds, a second V domain without disulphide bonds and a second tC2 with two disulphide bonds, i.e., as V-tC2-V-tC2. The gene encoding Humly9 was mapped to chromosome 1 by analysis of human/hamster hybrids, and more specifically to the 1q22 region by in situ hybridization. The protein sequence data support the view that Humly9 belongs to the immunoglobulin-superfamily subgroup which includes CD48, CD2, and LFA-3.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8537117     DOI: 10.1007/bf00186599

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  19 in total

1.  A year in the life of the immunoglobulin superfamily.

Authors:  A F Williams
Journal:  Immunol Today       Date:  1987

2.  Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes.

Authors:  D W Bailey
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

3.  A role in transmembrane signaling for the cytoplasmic domain of the CD2 T lymphocyte surface antigen.

Authors:  Q He; A D Beyers; A N Barclay; A F Williams
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

4.  Genetic and functional relationships of the retroviral and lymphocyte alloantigen loci on mouse chromosome 1.

Authors:  C A Kozak; W F Davidson; H C Morse
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  An alloantigen selective for B cells: Ly-17.1.

Authors:  F W Shen; E A Boyse
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

6.  T100: a new murine cell surface glycoprotein detected by anti-Lyt-2.1 serum.

Authors:  P J Durda; S C Boos; P D Gottlieb
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

7.  CD48 is a low affinity ligand for human CD2.

Authors:  M S Sandrin; E Mouhtouris; H A Vaughan; H S Warren; C R Parish
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

8.  Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production.

Authors:  H C Chang; P Moingeon; P Lopez; H Krasnow; C Stebbins; E L Reinherz
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

9.  The human LFA-3 gene is located at the same chromosome band as the gene for its receptor CD2.

Authors:  W A Sewell; R W Palmer; N K Spurr; D Sheer; M H Brown; Y Bell; M J Crumpton
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

10.  A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.

Authors:  A R Arulanandam; P Moingeon; M F Concino; M A Recny; K Kato; H Yagita; S Koyasu; E L Reinherz
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  5 in total

1.  Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells.

Authors:  Zhongjun Dong; Mario-Ernesto Cruz-Munoz; Ming-Chao Zhong; Riyan Chen; Sylvain Latour; André Veillette
Journal:  Nat Immunol       Date:  2009-08-02       Impact factor: 25.606

2.  Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.

Authors:  Djordje Atanackovic; Jens Panse; York Hildebrandt; Adam Jadczak; Sebastian Kobold; Yanran Cao; Julia Templin; Sabrina Meyer; Henrike Reinhard; Katrin Bartels; Nesrine Lajmi; Axel R Zander; Andreas H Marx; Carsten Bokemeyer; Nicolaus Kröger
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

3.  The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.

Authors:  Flora Cartier; Ingrid Marcq; Florian Douam; Christèle Ossart; Aline Regnier; Véronique Debuysscher; Dimitri Lavillette; Hicham Bouhlal
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

Review 4.  Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Authors:  Gregory Fouquet; Ingrid Marcq; Véronique Debuysscher; Jagadeesh Bayry; Amrathlal Rabbind Singh; Abderrahmane Bengrine; Eric Nguyen-Khac; Mickael Naassila; Hicham Bouhlal
Journal:  Oncotarget       Date:  2018-02-26

5.  Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.

Authors:  Ingrid Marcq; Rémy Nyga; Flora Cartier; Rabbind Singh Amrathlal; Christèle Ossart; Hakim Ouled-Haddou; Hussein Ghamlouch; Antoine Galmiche; Denis Chatelain; Luciane Lamotte; Véronique Debuysscher; Vincent Fuentes; Eric Nguyen-Khac; Jean-Marc Regimbeau; Jean-Pierre Marolleau; Sylvain Latour; Hicham Bouhlal
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.